These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 3655404)
1. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody. Dietzschold B; Tollis M; Rupprecht CE; Celis E; Koprowski H J Infect Dis; 1987 Nov; 156(5):815-22. PubMed ID: 3655404 [TBL] [Abstract][Full Text] [Related]
2. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice. Lafon M; Bourhy H; Sureau P Vaccine; 1988 Aug; 6(4):362-8. PubMed ID: 2461007 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. Bunschoten H; Gore M; Claassen IJ; Uytdehaag FG; Dietzschold B; Wunner WH; Osterhaus AD J Gen Virol; 1989 Feb; 70 ( Pt 2)():291-8. PubMed ID: 2471786 [TBL] [Abstract][Full Text] [Related]
4. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Wiktor TJ; Macfarlan RI; Reagan KJ; Dietzschold B; Curtis PJ; Wunner WH; Kieny MP; Lathe R; Lecocq JP; Mackett M Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7194-8. PubMed ID: 6095272 [TBL] [Abstract][Full Text] [Related]
6. Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein. Bunschoten H; Klapmuts RJ; Claassen IJ; Reyneveld SD; Osterhaus AD; Uytdehaag FG J Gen Virol; 1989 Jun; 70 ( Pt 6)():1513-21. PubMed ID: 2471814 [TBL] [Abstract][Full Text] [Related]
7. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein. Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein. Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075 [TBL] [Abstract][Full Text] [Related]
10. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination. Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157 [TBL] [Abstract][Full Text] [Related]
11. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant. Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474 [TBL] [Abstract][Full Text] [Related]
12. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327 [TBL] [Abstract][Full Text] [Related]
13. Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Dietzschold B; Wang HH; Rupprecht CE; Celis E; Tollis M; Ertl H; Heber-Katz E; Koprowski H Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9165-9. PubMed ID: 3480536 [TBL] [Abstract][Full Text] [Related]
14. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein. Flamand A; Wiktor TJ; Koprowski H J Gen Virol; 1980 May; 48(1):105-9. PubMed ID: 6155432 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the ERA antirabies vaccine against antigenic variants of rabies virus in various post-immunization periods]. Cordeiro CC; Silva EV; Miguel O; Germano PM Rev Saude Publica; 1990 Dec; 24(6):512-7. PubMed ID: 2103072 [TBL] [Abstract][Full Text] [Related]
16. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2. Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817 [TBL] [Abstract][Full Text] [Related]
17. Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses. Evans JS; Selden D; Wu G; Wright E; Horton DL; Fooks AR; Banyard AC J Gen Virol; 2018 Feb; 99(2):169-180. PubMed ID: 29300155 [TBL] [Abstract][Full Text] [Related]
18. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge. Liu X; Yang Y; Sun Z; Chen J; Ai J; Dun C; Fu ZF; Niu X; Guo X PLoS One; 2014; 9(2):e87105. PubMed ID: 24498294 [TBL] [Abstract][Full Text] [Related]
19. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice. Kaur M; Saxena A; Rai A; Bhatnagar R FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168 [TBL] [Abstract][Full Text] [Related]
20. Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens. da Fontoura Budaszewski R; Hudacek A; Sawatsky B; Krämer B; Yin X; Schnell MJ; von Messling V J Virol; 2017 Apr; 91(8):. PubMed ID: 28148801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]